Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maaike Anna Hempenius

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Histopathology|April 12, 2024
Considerable interlaboratory variation in PD-L1 positivity for head and neck squamous cell carcinoma in the Netherlands- A nationwide evaluation studyMaaike Anna Hempenius, Bregje M Koomen, Ivette A G Deckers, et al.
Histopathology|July 30, 2024
Quantitative comparison of immunohistochemical HER2-low detection in an interlaboratory studyMaaike Anna Hempenius, Maran A Eenkhoorn, Henrik Høeg, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 15, 2026
PD-L1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the NetherlandsMirte Dekker, Maaike Anna Hempenius, Geertruida H de Bock, et al.
Oral Oncology|August 22, 2022
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinomaMaaike Anna Hempenius, Sangeeta Kareshma Bisheshar, Lorian Slagter-Menkema, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2025
Interassay Comparison With Digital Image Analysis of 4 Routine Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry Assays in Primary Breast Cancer and Its MetastasisMaaike Anna Hempenius, Mieke C Zwager, Jeppe Thagaard, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Histopathology|April 12, 2024
Considerable interlaboratory variation in PD-L1 positivity for head and neck squamous cell carcinoma in the Netherlands- A nationwide evaluation studyMaaike Anna Hempenius, Bregje M Koomen, Ivette A G Deckers, et al.
Histopathology|July 30, 2024
Quantitative comparison of immunohistochemical HER2-low detection in an interlaboratory studyMaaike Anna Hempenius, Maran A Eenkhoorn, Henrik Høeg, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 15, 2026
PD-L1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the NetherlandsMirte Dekker, Maaike Anna Hempenius, Geertruida H de Bock, et al.
Oral Oncology|August 22, 2022
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinomaMaaike Anna Hempenius, Sangeeta Kareshma Bisheshar, Lorian Slagter-Menkema, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2025
Interassay Comparison With Digital Image Analysis of 4 Routine Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry Assays in Primary Breast Cancer and Its MetastasisMaaike Anna Hempenius, Mieke C Zwager, Jeppe Thagaard, et al.
Pageof 1